XTRM looking to break .003s early AM was .0043 just days

New Post Public Reply Private Reply Replies (0) Message Board
wayno2 SHEEPWOLF #82423
171
XTRM looking to break .003s early AM was .0043 just days ago and now CEO is tweeting go time, zero toxic, new R/M play
Market Cap Market Cap
1,617,877
02/11/2020
Authorized Shares
1,350,000,000
01/03/2020
Outstanding Shares
808,938,500
01/03/2020
Restricted
397,065,000
01/03/2020
Unrestricted Number of shares in the Public Float2
: 411,873,500 as of September 30, 2019
411,873,500 zero changes

01/03/2020 Extreme Biodiesel, Inc. Provides Corporate Update
Newsfile Corp.
Newsfile Corp
Boise, Idaho--(Newsfile Corp. - February 12, 2020) - Extreme Biodiesel, Inc. (OTC Pink: XTRM), is taking this opportunity to provide you, our valued shareholders, with an update on the progress of the Company in 2019 and provide a current status on our various fronts.

"Dear Shareholders,

We wanted to provide our valued shareholders with a corporate update, and 2019 year in review.

Financial years 2017, 2018, and 2019 have been posted on OTC markets and 2019 year- end filings are coming very shortly. Until we were current, the company continued to maintain our strategic silence. However, it's important to us that we let everyone know that we are continuing to build our business.

Locating and acquiring a viable business for Extreme Biodiesel, Inc. was our primarily adjective. This was a big, bold move for newly appointed management and a big investment knowing the past history of the former management.

Today, we are well positioned to finally begin to take advantage of all the hard work everyone has put in fixing the company. Although we thought we would have been here sooner, good things come to those with patience. We have several key and substantial announcements in the coming weeks and months about our newly acquired asset that will provide the company the financial stability it deserves. LIABILITIES
Current Liabilities
Accounts payable 1,221
Total current liabilities 1,221
Long-term Liabilities
Note payable - -
Total long-term liabilities - -
Total liabilities 1,221

https://backend.otcmarkets.com/otcapi/company...94/content

The Company's new website is near completion and will be released for viewing very soon.

In the meantime, we have been busy and continue to work hard and plan to update our shareholders on a much more regular basis please follow us on twitter @XTRMBio https://twitter.com/XTRMBio

Disclaimer: The Company relies upon the Safe Harbor Laws of 1933, 1934 and 1995 for all public news releases. The company may make forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are estimates that reflect the company's best judgment based upon current information. All investments involve risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors. Factors which could cause actual results to differ materially from those estimated by the company include, but are not limited to, government regulation; managing and maintaining growth; the effect of adverse publicity; litigation; competition; and other factors which may be identified from time to time in the company's public announcements.

Contact:
Extreme Biodiesel, Inc. info@extremebiodiesel.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/52282

https://www.newsfilecorp.com/newsinfo/52282/130
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tactical Comm Market: $19.39B by 2031 Amid 8.1% CAGR

Updated Category News Views 115

Riding the Tactical Communication Wave Alright, here’s something to chew on over your morning coffee. The tactical communication market is projected to balloon from USD 13.14 billion in 2026 to a whopping USD 19.39 billion by 2031. That’s an 8.1% CAGR if you’re keeping track—no small peanuts. So what's driving this surge? It’s all about security, modernization,...

Continue Reading
Hexagon Seals Waygate Deal, Targets Inspection Leadership

Updated Category News Views 34

Hexagon's Bold Move into Non-Destructive Testing Hexagon's latest play is turning heads in the measurement technology market. They've just wrapped up a strategic acquisition, snagging none other than Waygate Technologies from Baker Hughes. For those not familiar, Waygate's no small fry—this outfit's got a century-plus history in non-destructive testing (NDT) services....

Continue Reading
Tips to Pick the Right Primary Care Provider

Updated Category News Views 41

Deciding on Your Healthcare Anchor The quest for the perfect primary care provider isn't just routine; it's a cornerstone to your overall healthcare strategy. When Healthcare Services Expert Sheila A. Berschauer from Moses Lake Community Health lays it all out in HelloNation, she pinpoints selecting a provider as one of the mightiest decisions in your health journey. This...

Continue Reading
Wet Noses Innovates Human-Grade Pet Food at PLMA 2026

Updated Category News Views 65

Pet Food Revolution? Wet Noses Takes the PLMA Stage Okay, listen up, pet lovers and industry folks alike—seems like Wet Noses, that Washington-based veteran in the dog treat game, is shaking up the pet food world. After cruising through the pet aisle for almost three decades, they're making a splash at the PLMA 2026. Why should we care? Well, they’re pushing this...

Continue Reading
Potatoes vs. Candy: Halloween's Spuddy Surprise

Updated Category News Views 148

When Halloween rolls around, you expect rabid kids clamoring for candy corn and chocolate bars. But this year, Idaho threw a spud into the sweets machine. Idaho's Potatoes Steal the Show In an unexpected twist, the Idaho Potato Commission ran a zany experiment on Halloween: kids had to choose between their beloved Halloween candy and a genuine Idaho potato. Imagine the...

Continue Reading
Virginia Innovation Boosts Startups and Research Growth

Updated Category News Views 95

Virginia's Rising Innovation Ecosystem Virginia, a place you might not expect to hear much about in terms of innovation, is actually shaking things up and making waves on a national scale. Throwing their hat into the innovation arena, Virginia's landed itself a cozy #5 spot for its 'Innovation and Research Ecosystem,' according to Area Development's latest rankings. The...

Continue Reading
Doughy Reinvents Cookie Dough with Bold New Identity

Updated Category News Views 301

A Gourmet Transformation: Doughy's New Identity Cookie dough isn't just for sneaking off a spoon anymore, or at least that's what Doughy aims to redefine with its innovative new identity. Launched from Kelly Ramey's brainchild in her Santa Monica kitchen, Doughy's journey from a homemade recipe to a retail sensation is nothing short of remarkable. Love it or hate it, this...

Continue Reading
PG&E's $2B Delay: A Blame Game or Real Crisis?

Updated Category News Views 69

Just when you think the circus of energy utilities couldn't get any more outlandish, PG&E grabs the spotlight once more. Picture this: they've got the megaphone out, threatening to put the brakes on $2 billion in crucial infrastructure investments. Twenty-five thousand customers left hanging, just waiting for their lights to come on. As if that's not enough, PG&E is also...

Continue Reading
Choosing Suit or Tuxedo: Insights for Weddings

Updated Category News Views 0

Decoding Wedding Attire: Suit vs. Tuxedo When it comes to wedding attire, it’s not just a simple choice between a suit or tuxedo. It’s a cascading series of choices that hinge on a myriad of factors; everything from the time of day, venue, and the level of formality to personal style tweaks can sway this decision. Listen up: Men’s clothing gurus Tom Napoli and Rico...

Continue Reading
Bright Minds in Hot Water: Investigation Shakes Investors

Updated Category News Views 0

FDA Throws Wrench Into Bright Minds' Plans This ain't the first time a biotech company's dream has hit the skids, but Bright Minds Biosciences (NASDAQ:DRUG) found themselves in the meat grinder when the FDA threw their epilepsy trial plans under the bus. The partial clinical hold wasn't a gentle slap on the wrist, but a gut punch driven by mouse toxicity findings and...

Continue Reading
s" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles